Certara Showcases 2024 Research Wins With Over 100 Papers Published

Core Insights - Certara, Inc. has achieved significant recognition in 2024 with over 100 publications and 12 scientists listed among the top 2% of most cited researchers globally [1][2][3] Group 1: Company Achievements - Certara's scientists have been recognized for their contributions to drug development, with 12 researchers making it to the Stanford/Elsevier list of top-cited scientists [2][3] - The company emphasizes its science-driven approach, providing advanced biosimulation software and expert advice to clients for strategic decision-making [3] Group 2: Publications and Research Focus - In 2024, Certara's publications cover the entire drug discovery and development process, highlighting key trends in areas such as pediatric oncology, mechanistic modeling, and the use of real-world data [4][5] - Notable topics include the impact of physiologically-based pharmacokinetics (PBPK) modeling on global health and the role of pharmacometrics in clinical trials [5] Group 3: Client Base and Services - Certara serves over 2,400 clients, including biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries, showcasing its global reach and influence in the industry [6]